找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Design and Discovery; Inhibitors of Mitoge Surya K. De Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive lice

[復(fù)制鏈接]
查看: 46821|回復(fù): 37
樓主
發(fā)表于 2025-3-21 18:03:54 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱(chēng)Drug Design and Discovery
副標(biāo)題Inhibitors of Mitoge
編輯Surya K. De
視頻videohttp://file.papertrans.cn/285/284830/284830.mp4
概述Describes role of small molecules in the modulation of MAPK pathways in the development of future medicine therapies.Analyzes recent challenges in designing small molecule inhibitors of MAP kinases.Pr
圖書(shū)封面Titlebook: Drug Design and Discovery; Inhibitors of Mitoge Surya K. De Book 2024 The Editor(s) (if applicable) and The Author(s), under exclusive lice
描述.This book covers the important role small molecules can play in the modulation of stress-activated protein kinase (SAPK), also called the mitogen-activated protein kinase (MAPK) pathway, and the potential this may offer in enabling the development of future medicine therapies. It is clear that MAP kinase pathway therapies could continue to drive increasing interest in the field, both within academic laboratories and also in the biotechnology and pharmaceutical sectors. This book provides an overview of protein kinase inhibitors, the biological roles of MAP kinases, ATP-competitive and non-competitive inhibitors, covalent inhibitors, and more. This book is intended for professors in academia, researchers in pharmaceutical and biotechnology sectors working on protein kinases, and graduate students in pharmacy/chemistry..
出版日期Book 2024
關(guān)鍵詞Protein Kinase Inhibitors; Drug Design; Drug Delivery; Mitogen-Activated Protein Kinase Inhibitors; Clin
版次1
doihttps://doi.org/10.1007/978-3-031-75682-5
isbn_softcover978-3-031-75684-9
isbn_ebook978-3-031-75682-5
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書(shū)目名稱(chēng)Drug Design and Discovery影響因子(影響力)




書(shū)目名稱(chēng)Drug Design and Discovery影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Drug Design and Discovery網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Drug Design and Discovery網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Drug Design and Discovery被引頻次




書(shū)目名稱(chēng)Drug Design and Discovery被引頻次學(xué)科排名




書(shū)目名稱(chēng)Drug Design and Discovery年度引用




書(shū)目名稱(chēng)Drug Design and Discovery年度引用學(xué)科排名




書(shū)目名稱(chēng)Drug Design and Discovery讀者反饋




書(shū)目名稱(chēng)Drug Design and Discovery讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶(hù)組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:02:29 | 只看該作者
板凳
發(fā)表于 2025-3-22 00:38:08 | 只看該作者
Nathan B. Fountain,Fritz E. Dreifuss are in the market for the treatment of cancer and other diseases. Many research institutes discovered preclinical ATP-competitive inhibitors of MAP kinases using fragment-based drug design or optimization of their initial hit from high-throughput screening to improve in vitro potency only but lack
地板
發(fā)表于 2025-3-22 07:30:46 | 只看該作者
5#
發(fā)表于 2025-3-22 11:28:15 | 只看該作者
Excursus I: Values and Human Rights, specific target protein and effectively disrupt the activity of the target protein, which involve disease processes such as cancer progression, inflammatory responses, or infectious diseases. The reaction mechanisms of some FDA-approved covalent inhibitors are depicted. The binding mode of covalent
6#
發(fā)表于 2025-3-22 14:50:35 | 只看該作者
https://doi.org/10.1007/978-3-031-75682-5Protein Kinase Inhibitors; Drug Design; Drug Delivery; Mitogen-Activated Protein Kinase Inhibitors; Clin
7#
發(fā)表于 2025-3-22 20:00:24 | 只看該作者
8#
發(fā)表于 2025-3-23 00:30:09 | 只看該作者
9#
發(fā)表于 2025-3-23 05:27:37 | 只看該作者
10#
發(fā)表于 2025-3-23 09:20:20 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 05:09
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
抚远县| 屏东县| 黄平县| 永清县| 阿勒泰市| 锦屏县| 古丈县| 蓝山县| 绍兴县| 习水县| 鄂尔多斯市| 凤城市| 宁强县| 安徽省| 青铜峡市| 镇江市| 遵义市| 喀喇沁旗| 永新县| 东安县| 潮州市| 朔州市| 十堰市| 皮山县| 阿荣旗| 固阳县| 南康市| 龙川县| 云南省| 三都| 邯郸县| 辉南县| 富裕县| 铅山县| 兰西县| 将乐县| 旌德县| 睢宁县| 中阳县| 怀安县| 新晃|